Meso Scale Diagnostics, LLC v. Roche Diagnostics GMBH

CourtSupreme Court of Delaware
DecidedFebruary 8, 2021
Docket200, 2020
StatusPublished

This text of Meso Scale Diagnostics, LLC v. Roche Diagnostics GMBH (Meso Scale Diagnostics, LLC v. Roche Diagnostics GMBH) is published on Counsel Stack Legal Research, covering Supreme Court of Delaware primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Meso Scale Diagnostics, LLC v. Roche Diagnostics GMBH, (Del. 2021).

Opinion

IN THE SUPREME COURT OF THE STATE OF DELAWARE

MESO SCALE DIAGNOSTICS, § LLC., et al., § § No. 200, 2020 Plaintiffs Below, § Appellants, § § Court Below: Court of Chancery v. § of the State of Delaware § ROCHE DIAGNOSTICS GMBH, § et al., § C.A. No. 2019-0167 § Defendants Below, § Appellees. §

Submitted: December 9, 2020 Decided: February 8, 2021

Before VALIHURA, VAUGHN, TRAYNOR, MONTGOMERY-REEVES, Justices and RANJI, Judge,* constituting the Court en Banc.

Upon appeal from the Court of Chancery of the State of Delaware. AFFIRMED.

David L. Finger, Esquire, Finger & Slanina, Wilmington, Delaware, William S. Consovoy, Esquire, J. Michael Connolly, Esquire (argued), Consovoy McCarthy PLLC, Arlington, Virginia, Patrick Strawbridge, Esquire, Consovoy McCarthy PLLC, Boston, Massachusetts for Appellants.

Matthew E. Fischer, Esquire, Timothy R. Dudderar, Esquire, J. Matthew Belger, Esquire, Andrew H. Sauder, Esquire, Potter Anderson & Corroon LLP, Wilmington, Delaware; Of Counsel Thomas L. Shriner, Jr., Esquire (argued), James T. McKeown, Esquire, Foley & Lardner LLP, Milwaukee, Wisconsin for Appellees.

* Sitting by designation pursuant to Del. Const. Art. IV, § 12 and Supreme Court Rules 2(a) and 4(a) to complete the quorum. PER CURIAM: In 2010, Appellants Meso Scale Diagnostics, LLC and Meso Scale Technologies,

LLC (collectively “Meso”) filed suit in the Court of Chancery against Appellee entities

Roche Diagnostics GmbH, Roche Diagnostics Corp., Roche Holding Ltd., IGEN LS LLC,

Lilli Acquisition Corp., IGEN International, Inc., and Bioveris Corp. (collectively

“Roche”), all of which are or were affiliates or subsidiaries of the F. Hoffmann -- La Roche,

Ltd. family of pharmaceutical and diagnostics companies. Meso alleged two counts of

breach of contract. Roche prevailed at trial, and this Court affirmed the judgment in 2014.

On February 28, 2019, Meso brought a new action asking the court to reopen the

case, vacate the judgment entered after trial, and order a new trial. Meso alleged that the

Vice Chancellor who decided its case four years earlier had an undisclosed disabling

conflict, namely, that Roche’s counsel had been simultaneously representing him in an

unrelated federal suit challenging the constitutionality of Delaware’s law providing for

confidential business arbitration in the Court of Chancery, 10 Del. C. § 349 (“Section

349”). In that federal litigation, which ended in 2014, the Chancellor and Vice Chancellors

of the Court of Chancery, as the parties responsible for implementing the challenged

statute, were nominal defendants (hereinafter, the “Judicial Officers”).

The Court of Chancery denied relief and dismissed the action. Meso appeals.

For the following reasons, we AFFIRM the judgment of the Court of Chancery.

2 I. Factual and Procedural Background

Though this case reaches us as an appeal from the dismissal of Meso’s complaint

granting Roche’s motion pursuant to Court of Chancery Rule 12(b)(6), Meso’s “complaint”

is, in effect, substantively a motion for relief from a judgment under Court of Chancery

Rule 60(b), and in particular, under subparagraphs (b)(4) and (b)(6). Meso’s request for

relief was restyled as a separate action for the convenience and at the request of the trial

court. Roche’s corresponding dismissal motion likewise presents, in effect, its opposition

to the Rule 60(b) arguments raised by Meso. The Court of Chancery treated the motion

substantially as one seeking Rule 60(b) relief.1

We take the facts as pled by Meso.2 In so doing, we defer only to those facts Meso

alleged in its pleading and the reasonable inferences therefrom.3 We otherwise rely on the

trial court’s recitation of the facts.

1 Meso Scale Diagnostics, LLC v. Roche Diagnostics GMBH et al., Del. Ch. C.A. No. 2019-0167, at 19 (May 18, 2020) (Telephone Rulings of the Court on Defendants’ Motion to Dismiss) [Notice of Appeal Ex. A, hereinafter, “Order”] (stating that “this isn’t a vanilla 12(b)(6) motion. Rather, it is a motion that challenges a claim for extraordinary relief under Rule 60(b), that happens to have been sought by complaint rather than by motion.”). 2 See generally App. to Op. Br. at A017–28 (Complaint). 3 This accords with the deference given to well-pleaded facts under Rule 12(b)(6): Our review is limited to the well-pleaded allegations contained in the complaint. We accept all well-pleaded allegations as true, but we ignore conclusory allegations that lack specific supporting factual allegations. Finally, throughout our examination of dismissals under Rule 12(b)(6), we remain heedful of our duty to draw all reasonable inferences in favor of the non-movant. . . . Ramunno v. Cawley, 705 A.2d 1029, 1034 (Del. 1998) (internal citations and footnotes omitted).

3 Meso sued Roche on June 22, 2010 alleging two counts of breach of contract (“Meso

Litigation”).4 Then-Attorney Andre Bouchard represented Roche in that action, while Vice

Chancellor Parsons presided over the case. On April 8, 2011, the Vice Chancellor denied

Roche’s motion to dismiss the Meso Litigation.5

On October 25, 2011 the Delaware Coalition for Open Government, Inc. (the

“Coalition”) filed suit in the United States District Court for the District of Delaware

against the State of Delaware, as well as the Court of Chancery and the Judicial Officers,

including Vice Chancellor Parsons (“DelCOG Litigation”).6

The Coalition asserted a cause of action under 42 U.S.C. § 1983, the federal civil

rights statute. It alleged no specific misconduct by Vice Chancellor Parsons. Rather, it

alleged that Section 349 deprived the Coalition of its right to public access to judicial

proceedings under the First Amendment of the United States Constitution. The Coalition

sought a declaration to that effect, as well as injunctive relief barring further arbitrations

under the statute and rules. It also sought to unseal the records of prior arbitrations

conducted pursuant to Section 349.

The Coalition’s complaint included a prayer for attorney’s fees and a residual prayer

for “such other and further relief as the Court deems fair and just.”7 Aside from this

4 App. to Op. Br. at A018 (Complaint). 5 Meso Scale Diagnostics, LLC v. Roche Diagnostics GMBH, 2011 WL 1348438, at *1 (Del. Ch. Apr. 8, 2011). 6 See generally App. to Op. Br. at A030–34 (DelCOG Complaint). 7 Id. at A34.

4 mention of attorney’s fees, there is no other indication in the record that the Coalition

sought to recover damages, and Meso made clear that Vice Chancellor Parsons did not face

the prospect of money damages or other personal liability beyond the declaratory and

injunctive relief sought in his capacity as a judicial officer charged with implementing

Section 349.

The State retained then-Attorney Bouchard to represent it in the DelCOG Litigation

some time before November 29, 2011.8 At that time, then-Attorney Bouchard sent a letter

to the Court on behalf of all parties coordinating a briefing and oral argument schedule for

the cross-motions for judgment on the pleadings. As the letter indicates, the parties agreed

to stay discovery pending a ruling on those motions. Also copied on the letter were the

Coalition’s counsel and the counsel for the Judicial Officers, Professor Lawrence A.

Hamermesh of the Widener University - Delaware Law School.

The United States District Court for the District of Delaware held oral argument on

Free access — add to your briefcase to read the full text and ask questions with AI

Related

United Student Aid Funds, Inc. v. Espinosa
559 U.S. 260 (Supreme Court, 2010)
Tumey v. Ohio
273 U.S. 510 (Supreme Court, 1927)
Offutt v. United States
348 U.S. 11 (Supreme Court, 1954)
In Re Murchison.
349 U.S. 133 (Supreme Court, 1955)
Mayberry v. Pennsylvania
400 U.S. 455 (Supreme Court, 1971)
Stump v. Sparkman
435 U.S. 349 (Supreme Court, 1978)
Liljeberg v. Health Services Acquisition Corp.
486 U.S. 847 (Supreme Court, 1988)
Mireles v. Waco
502 U.S. 9 (Supreme Court, 1991)
Lapides v. Board of Regents of Univ. System of Ga.
535 U.S. 613 (Supreme Court, 2002)
Caperton v. A. T. Massey Coal Co., Inc.
556 U.S. 868 (Supreme Court, 2009)
Adrian G. Duplantier v. United States
606 F.2d 654 (Fifth Circuit, 1979)
State Ex Rel. Bardacke v. Welsh
698 P.2d 462 (New Mexico Court of Appeals, 1985)
Nellius v. Stiftel
402 A.2d 359 (Supreme Court of Delaware, 1978)
Dacey v. Connecticut Bar Assn.
441 A.2d 49 (Supreme Court of Connecticut, 1981)
Schremp v. Marvel
405 A.2d 119 (Supreme Court of Delaware, 1979)
Sargent County Bank v. Wentworth
500 N.W.2d 862 (North Dakota Supreme Court, 1993)

Cite This Page — Counsel Stack

Bluebook (online)
Meso Scale Diagnostics, LLC v. Roche Diagnostics GMBH, Counsel Stack Legal Research, https://law.counselstack.com/opinion/meso-scale-diagnostics-llc-v-roche-diagnostics-gmbh-del-2021.